The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin
Contributeurs/tricesGuedjo, Hervé; Guedj, J; Negro, Francesco; Lagging, M; Westin, J; Bochud, Pierre-Yves; Bibert, Stéphanie; Neumann, A U
Publié dansJournal of viral hepatitis, vol. 19, no. 7, p. 488-496
Date de publication2012
Résumé
Mots-clés
- Adult
- Antiviral Agents/administration & dosage
- Fatty Liver/pathology/virology
- Female
- Genotype
- Hepacivirus/classification/genetics/isolation & purification
- Hepatitis C, Chronic/complications/drug therapy/pathology/virology
- Humans
- Interferon-alpha/administration & dosage
- Liver/pathology
- Liver Cirrhosis/pathology/virology
- Male
- Middle Aged
- Polyethylene Glycols/administration & dosage
- Recombinant Proteins/administration & dosage
- Ribavirin/administration & dosage
- Treatment Outcome
- Viral Load
Groupe de recherche
Citation (format ISO)
GUEDJO, Hervé et al. The impact of fibrosis and steatosis on early viral kinetics in HCV genotype 1-infected patients treated with Peg-IFN-alfa-2a and ribavirin. In: Journal of viral hepatitis, 2012, vol. 19, n° 7, p. 488–496. doi: 10.1111/j.1365-2893.2011.01569.x
Fichiers principaux (1)
Article (Published version)
Identifiants
- PID : unige:27167
- DOI : 10.1111/j.1365-2893.2011.01569.x
- PMID : 22676361
ISSN du journal1352-0504